Clinical Trial Update: A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial of prednisone as adjunctive therapy for hospitalized patients with pulmonary tuberculosis and HIV co-infection was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Tuberculosis, HIV Infections | Phase 3 | Status: WITHDRAWN